TotalMarketCap

Arvinas

ARVNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$426.969 M

$6.52 -12.13%

Close of 6 Nov 2026

As of 6 Nov 2026, Arvinas (ARVN) has a market capitalization of $427.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$262.6M

#2177 by revenue

Earnings

-$81.0M

Loss-making

Shares outstanding

65,485,006

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #197Shattuck LabsSTTK$450.1M
  2. #198Gyre TherapeuticsGYRE$446.6M
  3. #199ArvinasARVN$427.0M
  4. #200OculisOCS$419.1M
  5. #201Phathom PharmaceuticalsPHAT$413.0M

What if Arvinas were worth as much as…

Open the what-if tool →

Gold $28.2T

$431,196.02

Per share 66,133× higher

Bitcoin $1.53T

$23,331.27

Per share 3,578× higher

Apple $5.02T

$76,594.37

Per share 11,747× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Arvinas are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.